Paul Stone
Direttore operativo presso 5AM Venture Management LLC
Patrimonio netto: 4 M $ in data 30/04/2024
Profilo
Paul A.
Stone's current job is as a Partner & Chief Compliance Officer at 5AM Venture Management LLC.
Formerly, Mr. Stone worked as a Director at The Assay Depot, Inc., Director at Cidara Therapeutics, Inc., Director at Save the Bay, Director at Homology Medicines, Inc., Chief Patent Counsel & Vice President at Symyx Technologies, Inc., Chief Patent Counsel & Senior Vice President at Ethos Pharmaceuticals, Inc., Chief Patent Counsel, SVP & General Counsel at Ilypsa, Inc., and Attorney at Senniger Powers LLP.
Mr. Stone's education includes an undergraduate degree from the University of Wisconsin in 1985 and a graduate degree from the University of Wisconsin in 1995.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC.
0.15% | 31/03/2024 | 108 726 ( 0.15% ) | 4 M $ | 30/04/2024 |
Posizioni attive di Paul Stone
| Società | Posizione | Inizio |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Direttore operativo | 26/03/2010 |
Precedenti posizioni note di Paul Stone
| Società | Posizione | Fine |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Direttore Finanziario/CFO | 10/11/2023 |
| Q32 BIO INC. | Direttore/Membro del Consiglio | 01/12/2015 |
| CIDARA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2014 |
Ethos Pharmaceuticals, Inc.
 Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethos Pharmaceuticals, Inc. used to develop peptide drugs. The company had operations in Philadelphia and Charlottesville. The company was headquartered in San Francisco, CA. | Consigliere Generale | 01/03/2009 |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/10/2007 |
Formazione di Paul Stone
| University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Symyx Technologies, Inc.
 Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Technology Services |
Ethos Pharmaceuticals, Inc.
Ethos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethos Pharmaceuticals, Inc. used to develop peptide drugs. The company had operations in Philadelphia and Charlottesville. The company was headquartered in San Francisco, CA. | Health Technology |
The Assay Depot, Inc.
 The Assay Depot, Inc. Miscellaneous Commercial ServicesCommercial Services The Assay Depot, Inc. operates as a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. It serves large and small pharmaceutical companies, government institutes, biotechnology companies, academic researchers and citizen scientists. The company was founded by Christopher L. Petersen, Andrew B. Martin, and Kevin D. Lustig in 2007 and is headquartered in Solana Beach, CA. | Commercial Services |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Senniger Powers LLP
 Senniger Powers LLP Miscellaneous Commercial ServicesCommercial Services Senniger Powers LLP provides legal services. It offers pro bono services, patents, and litigation services. The company is headquartered in St. Louis, MO. | Commercial Services |
| Save the Bay | |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
- Borsa valori
- Insiders
- Paul Stone
